Literature DB >> 31366807

How to Demonstrate the Impact of Cardiac Rehabilitation on Cardio-renal Protection.

Teruhiko Imamura1.   

Abstract

Entities:  

Keywords:  cardiopulmonary exercise; creatinine; heart failure

Mesh:

Year:  2019        PMID: 31366807      PMCID: PMC6949446          DOI: 10.2169/internalmedicine.3349-19

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


× No keyword cloud information.
To the Editor I have read with great interest the article of Kitajima and colleagues, who investigated the impact of long-term cardiac rehabilitation on cardio-renal protection in elderly patients with cardiovascular diseases (1). I have two concerns that would likely improve the implications of their findings. First, despite their statement on “long-term cardiac rehabilitation”, few patients [6/44 (14%)] completed 5 years of follow-up. A five-year complete cohort set with appropriate statistical comparisons would strengthen the implications of their findings. A repeat analysis of variance among those who completed 5 years of follow-up would be appropriate for a trend analysis. Second, to strengthen their finding that cardiac rehabilitation maintained the cardio-renal function, any efforts to prepare a control group are suggested. Patients with a similar background may have comparable outcomes, irrespective of cardiac rehabilitation. A randomized control trial would ideal, and a background-matched cohort without cardiac rehabilitation or a pre-cardiac rehabilitation cohort (i.e., pre vs. post comparison) would be an alternative control group.

The author states that he has no Conflict of Interest (COI).
  1 in total

1.  Possibility of Cardio-renal Protection by Long-term Cardiac Rehabilitation in Elderly Patients with Cardiovascular Diseases.

Authors:  Ken Kitajima; Kanta Fujimi; Takuro Matsuda; Masaomi Fujita; Kouji Kaino; Reiko Teshima; Yuki Ujifuku; Tomoe Horita; Maaya Sakamoto; Tadaaki Arimura; Yuhei Shiga; Etsuji Shiota; Shin-Ichiro Miura
Journal:  Intern Med       Date:  2019-04-17       Impact factor: 1.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.